These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25565570)

  • 1. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis.
    Hanai T; Shiraki M; Ohnishi S; Miyazaki T; Ideta T; Kochi T; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
    Hepatol Res; 2015 Nov; 45(11):1083-90. PubMed ID: 25565570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ichikawa Y; Joshita S; Umemura T; Shobugawa Y; Usami Y; Shibata S; Yamazaki T; Fujimori N; Komatsu M; Matsumoto A; Tanaka E
    Hepatol Res; 2017 Feb; 47(2):226-233. PubMed ID: 27029022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis.
    Xu WP; Wang ZR; Zou X; Zhao C; Wang R; Shi PM; Yuan ZL; Yang F; Zeng X; Wang PQ; Sultan S; Zhang Y; Xie WF
    J Dig Dis; 2018 Apr; 19(4):242-253. PubMed ID: 29607614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Yoh K; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Ishii A; Iijima H; Nakamura H; Nishiguchi S
    Hepatol Res; 2016 Nov; 46(12):1194-1202. PubMed ID: 26836229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
    Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.
    Yeh ML; Huang CF; Huang CI; Dai CY; Lin IH; Liang PC; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chen JJ; Yu ML; Chuang WL
    PLoS One; 2019; 14(8):e0220663. PubMed ID: 31393964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Ishii A; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    J Viral Hepat; 2016 Dec; 23(12):977-984. PubMed ID: 27476460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.
    Jekarl DW; Choi H; Lee S; Kwon JH; Lee SW; Yu H; Kim M; Kim Y; Sung PS; Yoon SK
    Ann Lab Med; 2018 Jul; 38(4):348-354. PubMed ID: 29611385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis.
    Toshima T; Shirabe K; Ikegami T; Yoshizumi T; Kuno A; Togayachi A; Gotoh M; Narimatsu H; Korenaga M; Mizokami M; Nishie A; Aishima S; Maehara Y
    J Gastroenterol; 2015 Jan; 50(1):76-84. PubMed ID: 24603981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma.
    Chuaypen N; Chittmittraprap S; Pinjaroen N; Sirichindakul B; Poovorawan Y; Tanaka Y; Tangkijvanich P
    Hepatol Res; 2018 Oct; 48(11):872-881. PubMed ID: 29732647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B.
    Ishii A; Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2017 Feb; 47(2):204-215. PubMed ID: 26990490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
    Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
    J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
    Umemura T; Joshita S; Sekiguchi T; Usami Y; Shibata S; Kimura T; Komatsu M; Matsumoto A; Ota M; Tanaka E
    Am J Gastroenterol; 2015 Jun; 110(6):857-64. PubMed ID: 25916223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis.
    Nishikawa H; Enomoto H; Iwata Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2016 Jun; 46(7):613-21. PubMed ID: 26406984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis.
    Kono M; Nakamura Y; Oyama Y; Mori K; Hozumi H; Karayama M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Yamada M; Hamada E; Colby TV; Maekawa M; Suda T
    Respir Med; 2016 Jun; 115():46-52. PubMed ID: 27215503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.
    Nishikawa H; Enomoto H; Iwata Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Ishii A; Iijima H; Nishiguchi S
    Hepatol Res; 2016 May; 46(6):575-83. PubMed ID: 26418076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.
    Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Itokawa N; Kondo C; Kato K; Hatori T; Hano H; Oikawa T; Emoto N; Abe M; Kage M; Iwakiri K
    Hepatol Res; 2018 May; 48(6):424-432. PubMed ID: 29274190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association between serum Wisteria floribunda agglutinin-positive Mac-2-binding protein and prognosis of hepatocellular carcinoma after surgical treatment.
    Lin MT; Chiu SY; Chang KC; Li WF; Yong CC; Liu YW; Wang JH; Kuo FY; Huang CC; Wang CC; Hsiao CC; Hu TH
    Am J Cancer Res; 2022; 12(2):601-614. PubMed ID: 35261790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA
    Inoue T; Tsuzuki Y; Iio E; Shinkai N; Matsunami K; Fujiwara K; Matsuura K; Nojiri S; Tanaka Y
    Jpn J Infect Dis; 2018 May; 71(3):177-183. PubMed ID: 29491234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Kawanaka M; Tomiyama Y; Hyogo H; Koda M; Shima T; Tobita H; Hiramatsu A; Nishino K; Okamoto T; Sato S; Hara Y; Nishina S; Kawamoto H; Chayama K; Okanoue T; Hino K
    Hepatol Res; 2018 Jun; 48(7):521-528. PubMed ID: 29316028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.